Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): A randomised, placebo-controlled, phase 3 study

J. C. Yao, Nicola Fazio, S. Singh, Roberto Buzzoni, Carlo Carnaghi, Edward M. Wolin, Jiri Tomasek, Markus Raderer, Harald Lahner, M. Voi, Lida Bubuteishvili Pacaud, Nicolas Rouyrre, C. Sachs, J. W. Valle, G. Delle Fave, E. Van Cutsem, M. Tesselaar, Yasuhiro Shimada, D. Y. Oh, Jonathan R. StrosbergMatthew H. Kulke, M.E. Pavel, Salvatore Tafuto

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)968-977
Number of pages10
JournalThe Lancet
Issue number10022
Publication statusPublished - 2016

Cite this